MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1158/1078-0432.ccr-23-1106

Медицинская библиотека · Clinical cancer research : an official journal of the American Association for Cancer Research · 2023

Neoantigen Targetability in Progressive Advanced Melanoma.

van den Bulk Jitske, Verdegaal Els M E, van der Ploeg Manon, Visser Marten, Nunes Joana B, de Ru Arnoud H, Tjokrodirijo Rayman T N, Ijsselsteijn Marieke E, Janssen Natasja I, van der Breggen Ruud, de Bruin Linda, de Kok Pita, Janssen George M C, Ruano Dina, Kapiteijn Ellen H W, van Veelen Peter A, de Miranda Noel F C C, van der Burg Sjoerd H

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

PURPOSE: The availability of (neo)antigens and the infiltration of tumors by (neo)antigen-specific T cells are crucial factors in cancer immunotherapy. In this study, we aimed to investigate the targetability of (neo)antigens in advanced progessive melanoma and explore the potential for continued T-cell-based immunotherapy.

EXPERIMENTAL

DESIGN

We examined a cohort of eight patients with melanoma who had sequential metastases resected at early and later time points. Antigen-presenting capacity was assessed using IHC and flow cytometry. T-cell infiltration was quantified through multiplex immunofluorescence. Whole-exome and RNA sequencing were conducted to identify neoantigens and assess the expression of neoantigens and tumor-associated antigens. Mass spectrometry was used to evaluate antigen presentation. Tumor recognition by autologous T cells was assessed by coculture assays with cell lines derived from the metastatic lesions.

RESULTS

We observed similar T-cell infiltration in paired early and later metastatic (LM) lesions. Although elements of the antigen-presenting machinery were affected in some LM lesions, both the early and later metastasis-derived cell lines were recognized by autologous T cells. At the genomic level, the (neo)antigen landscape was dynamic, but the (neo)antigen load was stable between paired lesions.

CONCLUSIONS

Our findings indicate that subsequently isolated tumors from patients with late-stage melanoma retain sufficient antigen-presenting capacity, T-cell infiltration, and a stable (neo)antigen load, allowing recognition of tumor cells by T cells. This indicates a continuous availability of T-cell targets in metastases occurring at different time points and supports further exploration of (neo)antigen-specific T-cell-based therapeutic approaches for advanced melanoma.

Для цитирования: van den Bulk Jitske, Verdegaal Els M E, van der Ploeg Manon, Visser Marten, Nunes Joana B, de Ru Arnoud H, Tjokrodirijo Rayman T N, Ijsselsteijn Marieke E, Janssen Natasja I, van der Breggen Ruud, de Bruin Linda, de Kok Pita, Janssen George M C, Ruano Dina, Kapiteijn Ellen H W, van Veelen Peter A, de Miranda Noel F C C, van der Burg Sjoerd H. Neoantigen Targetability in Progressive Advanced Melanoma.. Clinical cancer research : an official journal of the American Association for Cancer Research. 2023. DOI: 10.1158/1078-0432.ccr-23-1106.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.